Inmaculada Castellano-Pitarch

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Current role of cannabis in therapeutics: A critical perspective.

Current role of cannabis in therapeutics: A critical perspective.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: June 18, 2026

Long-term persistence, safety and effectiveness of nusinersen in spinal muscular atrophy: a population-based study.

Long-term persistence, safety and effectiveness of nusinersen in spinal muscular atrophy: a population-based study.

Journal: Journal of neurology

Published: April 22, 2026

Adherence, Persistence, and Safety of Risdiplam in Spinal Muscular Atrophy: A Population-Based Cohort Study.

Adherence, Persistence, and Safety of Risdiplam in Spinal Muscular Atrophy: A Population-Based Cohort Study.

Journal: Neurology and therapy

Published: March 23, 2026

Multimodal characterisation of the SMN locus in SMA: copy number quantification and hybrid gene identification.

Multimodal characterisation of the SMN locus in SMA: copy number quantification and hybrid gene identification.

Journal: NPJ genomic medicine

Published: September 17, 2025

Real-world data on spinal muscular atrophy in Spain: Insights from over 500 individuals in the CuidAME project.

Real-world data on spinal muscular atrophy in Spain: Insights from over 500 individuals in the CuidAME project.

Journal: Journal of neuromuscular diseases

Published: July 29, 2025

Neurofilaments as Biomarkers of the Efficacy of Risdiplam Treatment in Early SMA Phenotypes Diagnosed by Newborn Screening.

Neurofilaments as Biomarkers of the Efficacy of Risdiplam Treatment in Early SMA Phenotypes Diagnosed by Newborn Screening.

Journal: Children (Basel, Switzerland)

Published: July 23, 2025

Upper limb motor function in individuals with SMA type 2: natural history and impact of therapies.

Upper limb motor function in individuals with SMA type 2: natural history and impact of therapies.

Journal: Journal of neurology

Published: March 06, 2025

The transition of patients with neuromuscular diseases: recommendations of the Spanish Society of Pediatric Neurology and the Spanish Society of Neurology. Endorsed by SENEP, SEN, and ASEM.

The transition of patients with neuromuscular diseases: recommendations of the Spanish Society of Pediatric Neurology and the Spanish Society of Neurology. Endorsed by SENEP, SEN, and ASEM.

Journal: Neurologia

Published: February 05, 2025

Delphi study on epidemiology, clinical management, disease burden, and treatment of paediatric patients with Duchenne muscular dystrophy in Spain.

Delphi study on epidemiology, clinical management, disease burden, and treatment of paediatric patients with Duchenne muscular dystrophy in Spain.

Journal: Neurologia

Published: December 24, 2024

Asymptomatic HyperCKemia in the Pediatric Population: A Prospective Study Utilizing Next-Generation Sequencing and Ancillary Tests.

Asymptomatic HyperCKemia in the Pediatric Population: A Prospective Study Utilizing Next-Generation Sequencing and Ancillary Tests.

Journal: Neurology

Published: December 12, 2024

Outcomes of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in the Valencian Community.

Outcomes of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in the Valencian Community.

Journal: International journal of neonatal screening

Published: November 28, 2024

Onasemnogene Abeparvovec Administration via Peripherally Inserted Central Catheter: A Case Report.

Onasemnogene Abeparvovec Administration via Peripherally Inserted Central Catheter: A Case Report.

Journal: Children (Basel, Switzerland)

Published: March 14, 2024

Showing 1-12 of 24

Last Updated: 09/26/2026